Connection
Bennett Chin to Prostate-Specific Antigen
This is a "connection" page, showing publications Bennett Chin has written about Prostate-Specific Antigen.
|
|
Connection Strength |
|
 |
|
 |
|
0.037 |
|
|
|
-
Zhang T, Dhawan MS, Healy P, George DJ, Harrison MR, Oldan J, Chin B, Armstrong AJ. Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone Acetate and Prednisone Treatment in Men With Metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2015 Aug; 13(4):392-399.
Score: 0.027
-
Lin K, Szabo Z, Chin BB, Civelek AC. The value of a baseline bone scan in patients with newly diagnosed prostate cancer. Clin Nucl Med. 1999 Aug; 24(8):579-82.
Score: 0.009